on 8 Jul 2021
Last Applicant/ Owned by
HEALTHCARE EXCELLENCE CANADA/EXCELLENCE EN SANTÉ CANADA
Healthcare Excellence Canada/Excellence en santé Canada,150 Kent Street, Suite 200,Ottawa
ONTARIO
CA
K1P0E4
Serial Number
927022 filed on 20th May 2021
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
927022
Mark
Action Taken | Status |
---|---|
Submitted for opposition 3 on 8th Jul 2021 | Inactivated |
Submitted for opposition 15 on 7th Jul 2021 | Correspondence Created |
Submitted for opposition 1 on 7th Jun 2021 | Created |
Submitted for opposition 31 on 7th Jun 2021 | Formalized |
Submitted for opposition 15 on 7th Jun 2021 | Correspondence Created |
Submitted for opposition 30 on 20th May 2021 | Filed |